Hiverac- Tenofovir Disoproxil Fumarate
Product Description
Ilko Ilac Sanayi ve Ticaret A.S
-
Country/Region:Türkiye
-
Founded:2012
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
Categories
Specifications
Ilko Ilac Sanayi ve Ticaret A.S
-
Country/Region:Türkiye
-
Founded:2012
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
More Products from Ilko Ilac Sanayi ve Ticaret A.S (99)
-
Product Ilflox- Levofloxacin Hemihydrate
Levofloxacin Hemihydrate is a fluoroquinolone antibacterial agent used in the treatment of susceptible bacterial infections requiring intravenous therapy. It acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair, resulting in bactericidal a... -
Product Moksefen- Moxifloxacin HCl
Moxifloxacin HCl is a broad-spectrum fluoroquinolone antibacterial agent used in the treatment of susceptible bacterial infections. It acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription and repair. The product is available as 400 mg ... -
Product Tricef- Cefdinir
Cefdinir is an oral third-generation cephalosporin antibiotic used in the treatment of susceptible bacterial infections. It acts by inhibiting bacterial cell wall synthesis, resulting in bactericidal activity against susceptible organisms. The portfolio includes 300 mg film-coated tablets in packs of 10 an... -
Product Cefdia- Cefixime
Cefixime is an oral third-generation cephalosporin antibiotic used in the treatment of susceptible bacterial infections. It exerts bactericidal activity by inhibiting bacterial cell wall synthesis. The product is available as 400 mg film-coated tablets in packs of 5 and 10 tablets, providing oral antibioti... -
Product Fortevir- Entecavir
Entecavir is an antiviral agent used in the treatment of chronic hepatitis B virus (HBV) infection. It is a guanosine nucleoside analogue that inhibits HBV DNA polymerase, thereby reducing viral replication. The product is available in 0.5 mg and 1 mg film-coated tablet strengths, each supplied in packs of... -
Product Fluson- Oseltamivir
Oseltamivir is an antiviral agent used for the treatment and prevention of influenza. It is a neuraminidase inhibitor that blocks the influenza virus neuraminidase enzyme, thereby limiting the release and spread of newly formed viral particles. The product is available as 75 mg capsules in packs of 10 caps... -
Product Hivent- Tenofovir Disoproxil Fumarate / Emtricitabine
Tenofovir Disoproxil Fumarate / Emtricitabine is a fixed-dose antiviral combination used in the management of human immunodeficiency virus (HIV) infection and, where approved, for HIV pre-exposure prophylaxis. Tenofovir disoproxil fumarate and emtricitabine are nucleotide/nucleoside reverse transcriptase i... -
Product Palbociclib
Palbociclib is an oral, selective inhibitor of cyclin-dependent kinases 4 and 6, designed to reduce tumour-cell proliferation by controlling cell-cycle progression. It is available as 75 mg, 100 mg and 125 mg tablets in packs of 7 or 21, supporting treatment cycles and individualized dose modification.Expe... -
Product Dasatinib
Dasatinib is an oral tyrosine kinase inhibitor targeting BCR-ABL and other relevant kinases involved in malignant cell proliferation. It is available as 20 mg, 50 mg and 70 mg film-coated tablets in packs of 60, and as 100 mg and 140 mg film-coated tablets in packs of 30. The broad strength range supports ... -
Product Ruxolitinib
Ruxolitinib is an oral Janus kinase 1 and 2 inhibitor developed to modulate abnormal JAK-STAT signalling associated with selected haematological disorders. It is available as 5 mg, 10 mg, 15 mg and 20 mg tablets in multiple pack sizes, including 14, 56 and 168 tablets depending on the strength, supporting ... -
Product Erlotinib
Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r... -
Product Sorafenib
Sorafenib is an oral multikinase inhibitor targeting signalling pathways involved in tumour-cell proliferation and tumour angiogenesis. It is available as 200 mg film-coated tablets in packs of 112, designed to support the established dosing schedule used in eligible oncology patients. Expected ...
